Sei Investments Co. lifted its position in shares of Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) by 71.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 93,157 shares of the company’s stock after buying an additional 38,917 shares during the quarter. Sei Investments Co.’s holdings in Palomar were worth $11,133,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Geneos Wealth Management Inc. bought a new stake in Palomar during the fourth quarter valued at $32,000. Kestra Advisory Services LLC bought a new position in shares of Palomar in the 4th quarter worth about $33,000. Rockefeller Capital Management L.P. raised its position in shares of Palomar by 81.5% in the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after acquiring an additional 132 shares in the last quarter. Frazier Financial Advisors LLC acquired a new position in shares of Palomar in the 4th quarter valued at about $54,000. Finally, Parallel Advisors LLC lifted its stake in shares of Palomar by 638.3% in the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after purchasing an additional 383 shares during the period. Institutional investors and hedge funds own 90.25% of the company’s stock.
Palomar Price Performance
Shares of NASDAQ PLMR opened at $133.79 on Friday. Palomar Holdings, Inc. has a fifty-two week low of $100.81 and a fifty-two week high of $147.62. The stock has a market cap of $3.55 billion, a price-to-earnings ratio of 18.63 and a beta of 0.41. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.49 and a current ratio of 0.49. The firm’s 50-day simple moving average is $124.31 and its 200 day simple moving average is $123.52.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the company. Keefe, Bruyette & Woods upped their target price on Palomar from $162.00 to $166.00 and gave the company an “outperform” rating in a research report on Wednesday, July 8th. Piper Sandler boosted their target price on shares of Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. boosted their target price on Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research report on Monday, July 20th. Evercore set a $152.00 price target on shares of Palomar in a research report on Friday, July 10th. Finally, Zacks Research lowered shares of Palomar from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 15th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $162.50.
Check Out Our Latest Analysis on Palomar
Insider Activity
In related news, President Jon Christianson sold 6,863 shares of Palomar stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $139.50, for a total transaction of $957,388.50. Following the transaction, the president owned 66,478 shares of the company’s stock, valued at $9,273,681. The trade was a 9.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mac Armstrong sold 3,500 shares of Palomar stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $112.96, for a total value of $395,360.00. Following the transaction, the chief executive officer directly owned 329,388 shares in the company, valued at approximately $37,207,668.48. The trade was a 1.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 20,843 shares of company stock worth $2,711,683 over the last 90 days. 3.70% of the stock is currently owned by corporate insiders.
About Palomar
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Further Reading
- Five stocks we like better than Palomar
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding PLMR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report).
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
